Journal of the National Cancer Institute , 107(12), djv275
12 (12) CD013190
At the same time, the industry is already shifting toward next-generation incretin therapies focused on improving efficacy, tolerability and convenience
Potential Benefits Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist
But if your weight loss has hit a wall, your healthcare provider can help determine if changing your dosage is appropriate
Mild nausea, headaches, fatigue, constipation, and diarrhea are common at higher doses and can go away over time.) Stay at the same dose and message your clinician If you start experiencing unmanageable side effects Unmanageable means theyre severe, prolonged, or significantly affect your ability to function